WallStreetZenWallStreetZen

NASDAQ: MXCT
Maxcyte Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Maxcyte revenue was $45.60M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $8.2M, down 21.7% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, MXCT annual revenue was $41.3M, with -6.7% growth year-over-year.

MXCT past revenue growth

How has MXCT's revenue growth performed historically?

Company
19.85%
Industry
11.21%
Market
37%
MXCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MXCT's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MXCT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MXCT revenue history

Current Revenue
$45.6M
Current Earnings
-$35.7M
Current Profit Margin
-78.4%

Be the first to know when MXCT announces revenue.

MXCT Revenue History By Year

MXCT Yearly RevenueMXCT RevenueMXCT ChangeMXCT Revenue Growth
2023-12-31$41.29M-$2.97M-6.72%
2022-12-31$44.26M$10.37M+30.59%
2021-12-31$33.89M$7.73M+29.52%
2020-12-31$26.17M$4.55M+21.04%
2019-12-31$21.62MN/AN/A

1 of 1

Maxcyte Revenue FAQ

What was MXCT's revenue last quarter?

Maxcyte (NASDAQ: MXCT) reported Q3 2024 revenue of $8.16 million up 2% year over year. In the same quarter last year, Maxcyte's revenue was $8.00 million.

What was Maxcyte's revenue in 2023?

Maxcyte's annual revenue for the twelve months ending Dec 31, 2023 was $41.29 million, a 6.72% decrease year over year.

How much does Maxcyte make in a day?

Based on Maxcyte annual revenue for the past four years, MXCT makes an average of $99,734.25 per day.

What was Maxcyte's annual revenue growth in the past year?

As of Q4 2024, Maxcyte's revenue has grown 19.85% year over year. This is 8.64 percentage points higher than the US Medical Devices industry revenue growth rate of 11.21%. Maxcyte's revenue in the past year totaled $45.60 million.

How much does Maxcyte make in a year?

Maxcyte's revenue by year for the past four years is:
  • Maxcyte's revenue for the twelve months ending Dec 31, 2023 was $41.29 million, a 6.72% decrease year over year.
  • Maxcyte's annual revenue for Dec 31, 2022 was $44.26 million, a 30.59% increase from 2021.
  • Maxcyte's annual revenue for 2021 was $33.89 million, a 29.52% increase from 2020.
  • Maxcyte's annual revenue for 2020 was $26.17 million, a 21.04% increase from 2019.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.